Christopher D.M. Fletcher, M.D., M.B.,B.S.
This page shows the publications co-authored by Christopher Fletcher and Andrew Beck.
Discovery of molecular subtypes in leiomyosarcoma through integrative molecular profiling. Oncogene. 2010 Feb 11; 29(6):845-54.
Clinically Relevant Molecular Subtypes in Leiomyosarcoma. Clin Cancer Res. 2015 Aug 01; 21(15):3501-11.
Expression of subtype-specific group 1 leiomyosarcoma markers in a wide variety of sarcomas by gene expression analysis and immunohistochemistry. Am J Surg Pathol. 2011 Apr; 35(4):583-9.
Genome-wide transcriptome analyses reveal p53 inactivation mediated loss of miR-34a expression in malignant peripheral nerve sheath tumours. J Pathol. 2010 Jan; 220(1):58-70.
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.